Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study

Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet (London, England). 2013;382(9904):1575–86.

Novick D, Haro JM, Suarez D, Vieta E, Naber D. Recovery in the outpatient setting: 36-month results from the schizophrenia outpatients health outcomes (SOHO) study. Schizophr Res. 2009;108(1–3):223–30.

Jaaskelainen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296–306.

De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr Res. 2007;92(1–3):68–73.

Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51(10):826–36.

Borgå P. Studies of long-term functional psychosis in three different counties in Sweden. Umeå, Sweden: Sweden; 1993.

Widerlöv B. Long-term functional psychosis: epidemiology in two different counties in Sweden. Uppsala: Uppsala, Sweden; 2007.

Forsell Y. The pathway to meeting need for mental health services in Sweden. Psychiatric services (Washington, DC). 2006;57(1):114–9.

Arvidsson H. Gender differences in needs and care of severely mentally ill persons: findings from a Swedish cross-sectional and longitudinal study. Int J Soc Psychiatry. 2010;56(4):424–35.

Stroup TS. Heterogeneity of treatment effects in schizophrenia. Am J Med. 2007;120(4 Suppl 1):S26–31.

Broekema WJ, de Groot IW, van Harten PN. Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Pharmacy world & science : PWS. 2007;29(3):126–30.

Megna JL, Kunwar AR, Mahlotra K, Sauro MD, Devitt PJ, Rashid A. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness. J Psychiatr Pract. 2007;13(2):129–37.

Bergendal A, Schioler H, Wettermark B, Bjorksten KS. Concomitant use of two or more antipsychotic drugs is common in Sweden. Therapeutic advances in psychopharmacology. 2015;5(4):224–31.

Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892–909.

Goldman LS. Medical illness in patients with schizophrenia. J Clin Psychiatry. 1999;60(Suppl 21):10–5.

Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Aust N Z J Psychiatry. 2014;48(11):1036–47.

Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8.

Suvisaari J, Perala J, Saarni SI, Harkanen T, Pirkola S, Joukamaa M, Koskinen S, Lonnqvist J, Reunanen A. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci. 2008;258(3):129–36.

Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, Lieberman JA. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006;86(1–3):15–22.

Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–33.

KU AA, Tek C. Prevalence of obesity and diabetes in patients with schizophrenia. World J Diabetes. 2017;15(8 (8)):390–6.

Carlsson AC, Wandell P, Osby U, Zarrinkoub R, Wettermark B, Ljunggren G. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health. BMC Public Health. 2013;13:670.

Saha S, Chant DC, Welham JL, McGrath JJ. The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatr Scand. 2006;114(1):36–9.

McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.

Hjern A, Wicks S, Dalman C. Social adversity contributes to high morbidity in psychoses in immigrants--a national cohort study in two generations of Swedish residents. Psychol Med. 2004;34(6):1025–33.

Perala J, Saarni SI, Ostamo A, Pirkola S, Haukka J, Harkanen T, Koskinen S, Lonnqvist J, Suvisaari J. Geographic variation and sociodemographic characteristics of psychotic disorders in Finland. Schizophr Res. 2008;106(2–3):337–47.

Jorgensen L, Allebeck P, Dalman C. Prevalence of psychoses in Stockholm County--a population-based study using comprehensive healthcare registers. Nord J Psychiatry. 2014;68(1):60–5.

Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. The Lancet Psychiatry. 2017;4(4):295–301.

Andersson T, Ahlbom A, Magnusson C, Carlsson S. Prevalence and incidence of diabetes in Stockholm County 1990-2010. PLoS One. 2014;9(8):e104033.

Lilja M, Eliasson M, Eriksson M, Soderberg S. A rightward shift of the distribution of fasting and post-load glucose in northern Sweden between 1990 and 2009 and its predictors. Data from the northern Sweden MONICA study. Diabet Med. 2013;30(9):1054–62.

Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.

Stockholm MAB. Medicinskt programarbete: Psykiatri: Programråd. Stockholm: Stockholm County Council; 2005.